Delivery Order SPE2DB24D2101-SPE2DB25FKLMM

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,527.18 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a pharmaceutical product, with a performance period through May 19, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,155.94 contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant...
This is a $17,254.03 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a prescription medication, with a period of performance through June 23, 2025. The contract is a Firm Fixed Price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has a ceiling value of $1,774.37 and a period of performance through June 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The delivery order has a firm fixed price of $2,082.84 and a completion date of June 11, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,082.84 firm fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medications, with a period of performance through June 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which...
This is a $6,020.25 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a completion date of September 29, 2023. The contract has a Firm Fixed Price pricing structure and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,351.83 firm fixed-price contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,973.94 contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK ML, with a ceiling value of $1,562.13 and a performance period ending on June 30, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKLMM
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REPATHA 140 MG/ML SURECLICK. The $6,631.20 contract has a performance period running through June 18, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing comprehensive global pharmaceutical support through December 2026. This delivery order is likely part of the broader IDC vehicle, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military and other government healthcare programs.

Generated 9/16/25, 9:58 AM